February 2, 2021 Experience Ocumension Therapeutics HK$793.8 million top-up placement of shares We advised the placing agent in connection with the equity offering
February 2, 2021 Experience Oesterreichische Kontrollbank $1.5 billion notes offering We advised the underwriters in connection with the global notes offering
February 2, 2021 Experience PLAYSTUDIOS business combination with Acies Acquisition We are advising PLAYSTUDIOS on its combination with Acies, a SPAC
February 2, 2021 Experience Ronshine China Holdings $200 million high-yield notes offering We advised the initial purchasers on the Regulation S offering
February 2, 2021 Experience SVB Financial $1.25 billion senior notes and perpetual preferred stock offerings We advised the underwriters on the concurrent investment-grade debt and depositary shares offerings
February 2, 2021 Experience Venus Medtech HK$1.4 billion placing of new H shares We advised Venus Medtech (Hangzhou) on its placement of new shares
February 1, 2021 Experience CureVac $450 million public offering We advised CureVac on the equity offering
February 1, 2021 Experience Province of British Columbia $1.75 billion global bond offering We advised the underwriters in connection with the investment-grade debt offering
February 1, 2021 Experience Seer $251.3 million stock offering We advised the underwriters on the SEC-registered equity offering
February 1, 2021 Experience Surgalign Holdings $37.5 million follow-on offering We advised the underwriters on the equity offering